Tankyrase inhibition aggravates kidney injury in the absence of CD2AP

Autor: Kuusela, S, Wang, H, Wasik, A A, Suleiman, H, Lehtonen, S
Přispěvatelé: Sanna Lehtonen research group, Department of Pathology, Medicum
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
Cancer Research
Poly Adenosine Diphosphate Ribose
Embryo
Nonmammalian

030232 urology & nephrology
POLY(ADP-RIBOSE) POLYMERASE
PLASMINOGEN-ACTIVATOR INHIBITOR-1
BETA-CATENIN
Podocyte
Rats
Sprague-Dawley

FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Mice
0302 clinical medicine
Tankyrases
Serpin E2
Renal Insufficiency
Zebrafish
beta Catenin
Cell Line
Transformed

Mice
Knockout

Kidney
Podocytes
Wnt signaling pathway
ACTIN CYTOSKELETON
EMBRYONIC-DEVELOPMENT
3. Good health
Cell biology
medicine.anatomical_structure
Original Article
Heterocyclic Compounds
3-Ring

Signal Transduction
STRUCTURAL BASIS
Beta-catenin
Lymphoid Enhancer-Binding Factor 1
Immunology
Biology
Nephropathy
03 medical and health sciences
Cellular and Molecular Neuroscience
medicine
Animals
Humans
Adaptor Proteins
Signal Transducing

CD2-ASSOCIATED PROTEIN
LARVAL ZEBRAFISH
Cell Biology
medicine.disease
Actin cytoskeleton
Molecular biology
CONGENITAL NEPHROTIC SYNDROME
Fibronectins
Rats
Cytoskeletal Proteins
030104 developmental biology
HEK293 Cells
biology.protein
1182 Biochemistry
cell and molecular biology

Genes
Lethal

3111 Biomedicine
Protein Processing
Post-Translational

Lymphoid enhancer-binding factor 1
Zdroj: Cell Death & Disease
Popis: Inappropriate activation of the Wnt/β-catenin pathway has been indicated in podocyte dysfunction and injury, and shown to contribute to the development and progression of nephropathy. Tankyrases, multifunctional poly(ADP-ribose) polymerase (PARP) superfamily members with features of both signaling and cytoskeletal proteins, antagonize Wnt/β-catenin signaling. We found that tankyrases interact with CD2-associated protein (CD2AP), a protein essential for kidney ultrafiltration as CD2AP-knockout (CD2AP−/−) mice die of kidney failure at the age of 6–7 weeks. We further observed that tankyrase-mediated total poly-(ADP-ribosyl)ation (PARylation), a post-translational modification implicated in kidney injury, was increased in mouse kidneys and cultured podocytes in the absence of CD2AP. The data revealed increased activity of β-catenin, and upregulation of lymphoid enhancer factor 1 (LEF1) (mediator of Wnt/β-catenin pathway) and fibronectin (downstream target of Wnt/β-catenin) in CD2AP−/− podocytes. Total PARylation and active β-catenin were reduced in CD2AP−/− podocytes by tankyrase inhibitor XAV939 treatment. However, instead of ameliorating podocyte injury, XAV939 further upregulated LEF1, failed to downregulate fibronectin and induced plasminogen activator inhibitor-1 (PAI-1) that associates with podocyte injury. In zebrafish, administration of XAV939 to CD2AP-depleted larvae aggravated kidney injury and increased mortality. Collectively, the data reveal sustained activation of the Wnt/β-catenin pathway in CD2AP−/− podocytes, contributing to podocyte injury. However, we observed that inhibition of the PARylation activity of tankyrases in the absence of CD2AP was deleterious to kidney function. This indicates that balance of the PARylation activity of tankyrases, maintained by CD2AP, is essential for normal kidney function. Furthermore, the data reveal that careful contemplation is required when targeting Wnt/β-catenin pathway to treat proteinuric kidney diseases associated with impaired CD2AP.
Databáze: OpenAIRE